Current pain and headache reports
-
Curr Pain Headache Rep · Aug 2012
ReviewSpinal cord stimulation in the treatment of cancer-related pain: "back to the origins".
Spinal cord stimulation (SCS) has been used in the treatment of chronic pain for more than 40 years. The most common indication for SCS in the USA is failed back surgery syndrome (FBSS). Interestingly, the first two spinal cord stimulators ever implanted were in patients suffering from bronchogenic carcinoma and pelvic cancer, respectively. ⋯ An increasing number of people suffer from cancer-related pain each year and many receive suboptimal relief. Given the demonstrated value of spinal cord stimulation in the treatment of neuropathic pain, spinal cord stimulation should be considered "earlier" as an adjunct to the treatment of cancer-related pain. In addition, with the improving survival rates associated with advances in cancer treatment, spinal cord stimulation may help reduce the risk of development of chronic neuropathic pain in survivors.
-
Headaches associated with papilledema may be both life-threatening as well as vision-threatening. This review will review the following clinical features: (1) the character of headaches associated with increased intracranial pressure; (2) the visual symptoms associated with papilledema; (3) the funduscopic findings of true papilledema versus pseudo-papilledema; (4) the role of ancillary ophthalmological testing such as visual fields and spectral domain optical coherence tomography; (5) the neuro-radiological evaluation of patients with headaches and papilledema; (6) the treatment of vision-threatening papilledema.